Search Results - "Journal of cardiovascular pharmacology"

Refine Results
  1. 1

    Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial by Panahi, Yunes, Kianpour, Parisa, Mohtashami, Reza, Jafari, Ramezan, Simental-Mendía, Luis E, Sahebkar, Amirhossein

    Published in Journal of cardiovascular pharmacology (01-09-2016)
    “…BACKGROUND:Nonalcoholic fatty liver disease (NAFLD) is one of the most common hepatic diseases in the general adult population. Dyslipidemia, hyperuricemia,…”
    Get full text
    Journal Article
  2. 2

    G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms by Jean-Charles, Pierre-Yves, Kaur, Suneet, Shenoy, Sudha K

    Published in Journal of cardiovascular pharmacology (01-09-2017)
    “…β-arrestin1 (or arrestin2) and β-arrestin2 (or arrestin3) are ubiquitously expressed cytosolic adaptor proteins that were originally discovered for their…”
    Get full text
    Journal Article
  3. 3

    Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway by Cui, Xiaojun, He, Zhangyou, Liang, Zihao, Chen, Zhenyi, Wang, Haifeng, Zhang, Jiankai

    Published in Journal of cardiovascular pharmacology (01-10-2017)
    “…Mesenchymal stem cells (MSCs) and their secreted exosomes exert a cardioprotective role in jeopardized myocardium. However, the specific effects and underlying…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury by Kolkhof, Peter, Delbeck, Martina, Kretschmer, Axel, Steinke, Wolfram, Hartmann, Elke, Bärfacker, Lars, Eitner, Frank, Albrecht-Küpper, Barbara, Schäfer, Stefan

    Published in Journal of cardiovascular pharmacology (01-07-2014)
    “…Pharmacological blockade of the mineralocorticoid receptor (MR) ameliorates end-organ damage in chronic heart failure. However, the clinical use of available…”
    Get full text
    Journal Article
  6. 6

    Role of Hypertension on the Severity of COVID-19: A Review by Peng, Mei, He, Jia, Xue, Ying, Yang, Xue, Liu, Shao, Gong, Zhicheng

    Published in Journal of cardiovascular pharmacology (01-11-2021)
    “…The novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Irisin Protects Heart Against Ischemia-Reperfusion Injury Through a SOD2-Dependent Mitochondria Mechanism by Wang, Zhen, Chen, Ken, Han, Yu, Zhu, Hua, Zhou, Xinyu, Tan, Tao, Zeng, Jing, Zhang, Jun, Liu, Yukai, Li, Yu, Yao, Yonggang, Yi, Jianxun, He, Duofen, Zhou, Jingsong, Ma, Jianjie, Zeng, Chunyu

    Published in Journal of cardiovascular pharmacology (01-12-2018)
    “…Irisin, a muscle-origin protein derived from the extracellular domain of the fibronectin domain-containing 5 protein (FNDC5), has been shown to modulate…”
    Get full text
    Journal Article
  9. 9
  10. 10

    NLRP3 Inflammasome in Acute Myocardial Infarction by Mauro, Adolfo G, Bonaventura, Aldo, Mezzaroma, Eleonora, Quader, Mohammed, Toldo, Stefano

    Published in Journal of cardiovascular pharmacology (01-09-2019)
    “…Acute myocardial infarction (AMI) is associated with the induction of a sterile inflammatory response that leads to further injury. The NACHT, leucine-rich…”
    Get full text
    Journal Article
  11. 11

    PDSS2 Inhibits the Ferroptosis of Vascular Endothelial Cells in Atherosclerosis by Activating Nrf2 by Yang, Kai, Song, Hejian, Yin, Delu

    Published in Journal of cardiovascular pharmacology (29-04-2021)
    “…Cardiovascular disease ranks the leading cause of mortality worldwide. Prenyldiphosphate synthase subunits collectively participate in the formation and…”
    Get full text
    Journal Article
  12. 12

    A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse by Marchetti, Carlo, Chojnacki, Jeremy, Toldo, Stefano, Mezzaroma, Eleonora, Tranchida, Nicla, Rose, Scott W, Federici, Massimo, Van Tassell, Benjamin W, Zhang, Shijun, Abbate, Antonio

    Published in Journal of cardiovascular pharmacology (01-04-2014)
    “…BACKGROUND:The formation of the NLRP3 inflammasome in the heart during acute myocardial infarction amplifies the inflammatory response and mediates further…”
    Get full text
    Journal Article
  13. 13

    Low-dose Sinapic Acid Abates the Pyroptosis of Macrophages by Downregulation of lncRNA-MALAT1 in Rats With Diabetic Atherosclerosis by Han, Yong, Qiu, Hong, Pei, Xing, Fan, Yigang, Tian, Hongyan, Geng, Jie

    Published in Journal of cardiovascular pharmacology (01-02-2018)
    “…Pyroptosis is a type of programmed cell death, which has been associated with multiple inflammatory diseases including diabetic atherosclerosis (DA). This…”
    Get full text
    Journal Article
  14. 14

    Dapagliflozin Attenuates Contrast-induced Acute Kidney Injury by Regulating the HIF-1α/HE4/NF-κB Pathway by Huang, Xu, Guo, Xiaoxu, Yan, Gaoliang, Zhang, Yang, Yao, Yuyu, Qiao, Yong, Wang, Dong, Chen, Gecai, Zhang, Weiwei, Tang, Chengchun, Cao, Feng

    Published in Journal of cardiovascular pharmacology (01-06-2022)
    “…Contrast-induced acute kidney injury (CI-AKI) causes clinically acquired nephropathy in patients who undergo coronary interventions. Hypoxic injury to proximal…”
    Get full text
    Journal Article
  15. 15

    Panax Notoginseng Saponins Attenuate Myocardial Ischemia-Reperfusion Injury Through the HIF-1α/BNIP3 Pathway of Autophagy by Liu, Xin-Wen, Lu, Meng-Kai, Zhong, Hui-Ting, Wang, Li-Hong, Fu, Yong-Ping

    Published in Journal of cardiovascular pharmacology (01-02-2019)
    “…BACKGROUND AND OBJECTIVE:Panax Notoginseng Saponins (PNS) is a formula of Chinese medicine commonly used for treating ischemia myocardial in China. However,…”
    Get full text
    Journal Article
  16. 16

    Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials by Zheng, Ru-Jie, Wang, Yue, Tang, Jun-Nan, Duan, Jie-Ying, Yuan, Ming-Yue, Zhang, Jin-Ying

    Published in Journal of cardiovascular pharmacology (01-02-2022)
    “…Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented effects on reducing hospitalization for heart failure and cardiovascular mortality,…”
    Get full text
    Journal Article
  17. 17

    Energy Metabolic Phenotype of the Cardiomyocyte During Development, Differentiation, and Postnatal Maturation by Lopaschuk, Gary D, Jaswal, Jagdip S

    Published in Journal of cardiovascular pharmacology (01-08-2010)
    “…Dramatic maturational changes occur in cardiac energy metabolism during cardiac development, differentiation, and postnatal growth. These changes in energy…”
    Get full text
    Journal Article
  18. 18

    Fibroblasts and Myofibroblasts: What Are We Talking About? by Baum, Jennifer, Duffy, Heather S

    Published in Journal of cardiovascular pharmacology (01-04-2011)
    “…Cardiac myocytes, although large enough to make up most of the heart volume, are only a minority of cells within the heart with fibroblasts and blood vessel…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Inclisiran: A Novel Agent for Lowering Apolipoprotein B-Containing Lipoproteins by Warden, Bruce A., Duell, P. Barton

    Published in Journal of cardiovascular pharmacology (01-08-2021)
    “…Hypercholesterolemia is a leading cause of cardiovascular morbidity and mortality. Accordingly, efforts to lower apolipoprotein B-containing lipoproteins in…”
    Get full text
    Journal Article